Effusions complicating malignant disease frequently contain easily recognisable neoplastic cells. In other cases, however, malignant cells are not seen or else their identification is too doubtful to justify a positive report.
One means by which diagnostic accuracy may be increased in such cases is to use immunocytochemical techniques. Several laboratories have explored this approach (see references in preceding paper) ' and have reported that neoplastic cells in serous effusions can be identified in this way without difficulty. The most important question is whether these methods can reveal tumour cells in samples which otherwise would be reported "negative" for malignancy. 2 We have therefore analysed a series of serous effusion samples, none of which had been reported to contain neoplastic cells on routine cytological examination, but which all came from patients shown to have malignant disease. The aim of this study was to decide whether immunocytochemical techniques have a practical role to play in the routine diagnosis of cytological samples.
Material and methods
PATIENTS AND SAMPLES ( (ii) Positive result (12 patients) In each of these cases, providing in all 15 specimens, at least two of the antibodies gave positive staining, and there were at least five stained cells which were morphologically consistent with carcinoma cells. The original Giemsa-stained cytological smears from these cases were reviewed and in three samples it was possible to detect clearly malignant cells Patients with more than one effusion gave similar results and are entered as a single case in these groups a = patients with two effusions e b = patients with three effusions j ach letter represents a patient.
group.bmj.com on April 13, 2017 -Published by http://jcp.bmj.com/ Downloaded from which had been missed. These three specimens were all from cases in which immunocytochemical staining had revealed more than 20 neoplastic cells labelled with each of the three monoclonal antibodies.
In one effusion, due to carcinoma of the colon, the labelled cells corresponded to a cell type subsequently shown to secrete mucin (amylase-resistant PAS-positive staining in the distended cytoplasm). In two other cases, malignant cells were reported on routine examination of preceding or subsequent effusions, but not on the one used for this study.
(iii) Inconclusive result (10 patients) In these cases, comprising a total of 13 samples, immunocytochemical staining revealed less than five positively reacting cells in any individual smear. In eight of them the morphology of these cells seemed on review to be consistent with malignancy. One patient with carcinoma of the lung had single cells positive with anti-CEA and Ca 1 in each of two effusions. The cells had features of oat cells but were too few for a conclusive diagnosis.
In two cases the evidence was even weaker. One case of carcinoma of the prostate showed cells staining strongly with HMFG-2, but not with Ca 1 or anti-CEA. The other case, with carcinoma of the colon, showed only one weakly Ca 1-positive cell.
The "inconclusive" group therefore varies from cases in which the evidence is very suggestive but not compelling, down to those in which it depends upon the reaction of a single cell.
Discussion
Pleural, peritoneal and pericardial effusions are commonly encountered in patients suffering from malignant disease, but in this laboratory, as a result of cautious reporting, only about 60% are given "positive" or "suspicious" reports for malignant cells (Table 3) . It is to be expected that a proportion Ghosh, Mason, Spriggs of the remaining 40% of serous effusions do not in fact contain any malignant cells, since they result from processes other than neoplastic involvement of serous membranes-for example, pulmonary collapse. On the other hand, there must be a number of specimens in which malignant cells are too few, or else not distinctive enough, to be recognisable on conventional cytological examination. Failure to detect these cells may have important implications in terms of patient management, and therefore any procedure which can reduce the threshold for their detection is to be welcomed, provided that the "false-positive" rate remains near to zero.
In the present study immunocytochemical staining with a small panel of monoclonal antibodies detected presumably malignant cells which had not previously been noticed in almost 30% (12 of 41) of cytologically "benign" serous effusions from patients with malignant disease. In addition 17% of samples gave immunocytochemical reactions which were suggestive of malignancy but insufficientper se to allow a confident diagnosis.
We cannot of course provide formal proof that the cells revealed by immunocytochemical staining were indeed malignant. We can only point to the rarity of false positives in our previous studies of unequivocally benign effusions: anti-CEA has given no such reactions in a series of 22 non-malignant samples' (and this high specificity has recently been documented by Sehested et al.7) Ca 1 has only given two false positive results' 5in 47 samples studied (combined data from two series). In this context it may be noted that we have not observed the high positivity rate for Ca 1 in benign mesothelium which was reported by Burnett et al in their immunocytochemical study of pleural biopsies,8 or by Pallesen et al using cells fixed in suspension before washing and sedimenting.9 Antibody HMFG-2 has proved less specific than anti-CEA and antibody Ca 1 for malignant cells but has often 
